NCI Clinical Trials and Translational Research Advisory Committee (CTAC) - July 2018
The CTAC makes recommendations on the NCI-supported national clinical trials enterprise to build a strong scientific infrastructure by bringing together a broadly developed and engaged coalition of stakeholders involved in the clinical trial process.For more information go tohttp://deainfo.nci.nih.gov/advisory/ctac/ctacmeetings.htmAir date: 7/11/2018 8:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - April 25, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Embedded Pragmatic Clinical Trials of Therapeutic A vs. B Interventions Workshop
This one-day Workshop will explore challenges and strategies for planning and implementing embedded pragmatic clinical trials (PCT) that compare two or more therapeutic medical regimens. Pragmatic trials differ from traditional clinical trials, as they test interventions or practices delivered in real-world settings. If conducted within integrated health care systems, embedded PCT can leverage existing infrastructure to answer important clinical questions in a cost-effective manner. They can also bridge the critical gap between clinical evidence, practice and policy in health care delivery.
The NIH Health Care Systems Res...
Source: Videocast - All Events - April 24, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
B cells in Autoimmune diseases: Focus on Sj ö gren's Syndrome
NIDCR Clinical Research Fellowship Grand Rounds
B cells play a complex role in the development of systemic autoimmune diseases, especially in primary Sj ö gren's syndrome, a progressive condition that damages saliva and tear glands and leads to dry mouth, dry eyes, and other symptoms. Dr. Jacques-Olivier Pers will outline growing evidence that regulatory B lymphocytes (Breg) may blunt the pathogenesis of systemic autoimmune disease, and thus may be potential targets for treatment. Studies of distinct B cell subsets that play differing roles in autoimmune diseases are providing new insights into Breg development and immune...
Source: Videocast - All Events - April 11, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
At the Crossroads of Social Media and Clinical Trials: A Workshop on the Future of Clinician, Patient and Community Engagement (Day 1)
In the modern age of digital media, a large majority of adults now use online resources to obtain health information and connect with clinicians, other patients and patient-centered communities. Consequently, there is an opportunity to improve patient engagement and education surrounding clinical trials through the use of social media platforms. The primary objective of NCI ’ s “ At the Crossroads of Social Media and Clinical Trials: A Workshop on the Future of Clinician, Patient and Community Engagement ” is to convene experts in clinical trials, social media, communications as well as patients and patient advocates...
Source: Videocast - All Events - April 10, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
At the Crossroads of Social Media and Clinical Trials: A Workshop on the Future of Clinician, Patient and Community Engagement (Day 2)
In the modern age of digital media, a large majority of adults now use online resources to obtain health information and connect with clinicians, other patients and patient-centered communities. Consequently, there is an opportunity to improve patient engagement and education surrounding clinical trials through the use of social media platforms. The primary objective of NCI ’ s “ At the Crossroads of Social Media and Clinical Trials: A Workshop on the Future of Clinician, Patient and Community Engagement ” is to convene experts in clinical trials, social media, communications as well as patients and patient advocates...
Source: Videocast - All Events - April 10, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
CC Grand Rounds: 1) Localized Bladder Cancer: Management, Challenges, and Clinical Trials and 2) Advanced and Metastatic Bladder Cancer: Management, Challenges, and Clinical Trials
For more information go tohttp://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 4/18/2018 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - March 26, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Leveraging Social Media to Improve Clinical Trials Awareness (Day 2)
In the modern age of digital media, a large majority of adults now use online resources to obtain health information and connect with clinicians, other patients and patient-centered communities. Consequently, there is an opportunity to improve patient engagement and education surrounding clinical trials through the use of social media platforms. The primary objective of NCI ’ s “ Leveraging Social Media to Improve Clinical Trials Awareness in The Community ” is to convene experts in clinical trials, social media, communications as well as patients and patient advocates in a highly interactive setting to learn, networ...
Source: Videocast - All Events - March 13, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Leveraging Social Media to Improve Clinical Trials Awareness (Day 1)
In the modern age of digital media, a large majority of adults now use online resources to obtain health information and connect with clinicians, other patients and patient-centered communities. Consequently, there is an opportunity to improve patient engagement and education surrounding clinical trials through the use of social media platforms. The primary objective of NCI ’ s “ Leveraging Social Media to Improve Clinical Trials Awareness in The Community ” is to convene experts in clinical trials, social media, communications as well as patients and patient advocates in a highly interactive setting to learn, networ...
Source: Videocast - All Events - March 13, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
NCI Post-Treatment Surveillance Workshop - March 2018 (Day 2)
To discuss issues in post treatment surveillance given the current advances in imaging and in vitro diagnostics. Specific discussions will occur in Breast, Colon, NSCLS, Colorectal Cancer and Testicular cancer. Identify and prioritize histologies and tools that are most suitable to be evaluated in this setting, in NCTN and NCORP clinical trials.Air date: 3/27/2018 8:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - February 15, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
NCI Post-Treatment Surveillance Workshop - March 2018 (Day 1)
To discuss issues in post treatment surveillance given the current advances in imaging and in vitro diagnostics. Specific discussions will occur in Breast, Colon, NSCLS, Colorectal Cancer and Testicular cancer. Identify and prioritize histologies and tools that are most suitable to be evaluated in this setting, in NCTN and NCORP clinical trials.Air date: 3/26/2018 8:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - February 15, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Proteogenomics of Breast Cancer
NCI's Center for Cancer Research (CCR) Grand Rounds
Dr. Matthew Ellis ’ s clinical and basic research focuses on breast cancer. He has developed neoadjuvant endocrine therapy as an alternative to chemotherapy for promoting breast-conserving therapy in postmenopausal women with ER+ HER2- stage 2 and 3 disease. He developed and validated the Ki67 proliferation marker-based Preoperative Endocrine Prognostic Index which is now undergoing a large validation study (the ALTERNATE study). These clinical studies have provided the clinical context and tumor specimens for seminal investigations into the ER+ breast cancer somatic ge...
Source: Videocast - All Events - January 30, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
National Advisory Council for Complementary and Integrative Health (NACCIH) – February 2018
This is the Open Session of the 65th meeting of the National Advisory Council for Complementary and Integrative Health held on 02/09/2018. The agenda for this Open Session includes presentations on the status of NCCIH from David Shurtleff, PhD, the Clinical Trials Policy at NIH from Michael Lauer, MD, PhD, a Concept Clearance, and an Update on Clinical Trials at NCCIH. For more information on NCCIH and the NACCIH, see https://nccih.nih.gov/about/naccih.Air date: 2/9/2018 9:45:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - January 10, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
NCI Clinical Trials and Translational Research Advisory Committee (CTAC) - March 2018
The CTAC makes recommendations on the NCI-supported national clinical trials enterprise to build a strong scientific infrastructure by bringing together a broadly developed and engaged coalition of stakeholders involved in the clinical trial processFor more information go tohttp://deainfo.nci.nih.gov/advisory/ctac/ctacmeetings.htmAir date: 3/7/2018 11:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - January 5, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Personalized vs. Precision? Let ’ s Call It Medicine
NCI's Center for Cancer Research (CCR) Grand Rounds
Dr. Howard McLeod is Medical Director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He is Chair of the Department of Individualized Cancer Management and a State of Florida Endowed Chair in Cancer Research. He is also a senior member of the Division of Population Sciences and Professor at the University of South Florida. Dr. McLeod is Chair of the NHGRI eMERGE network external scientific panel and a recent member of the FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology and the NIH Human Genome Advisory Coun...
Source: Videocast - All Events - December 4, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
Loss of Type I Interferon Negative Regulation – Lessons from Human Genetics
Immunonology IG Seminar
Dr. Dusan Bogunovic is an Assistant Professor in the Department of Microbiology, Department of Pediatrics at Mindich Child Health and Development Institute at the Icahn School of Medicine at Mount Sinai in New York. He obtained his PhD in Immunology at NYU Medical School where he studied innate immune signaling in dendritic cells as a function of their ability to mount an adaptive immune response against melanoma. That work has inspired two clinical trials. He did his postdoctoral fellowship at The Rockefeller University with Jean-Laurent Casanova where he studied how host genetics contribute to inf...
Source: Videocast - All Events - November 2, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
